Congenital myasthenic syndrome with episodic apnoea (CMS-EA)

Evidence-based neurology checklist on congenital myasthenic syndrome with episodic apnoea (cms-ea): Genetic mutations CHAT: this accounts for most cases SLC5A7 RAPSN Myasthenic features Episodic apnoea Obstetric features Other features Triggers for crisis Brain pathology Treatment

Genetic mutations

  • CHAT: this accounts for most cases
  • SLC5A7 
  • RAPSN

Myasthenic features

Episodic apnoea

Obstetric features

Other features

Triggers for crisis

Brain pathology

Treatment

References

  1. McMacken G, Whittaker RG, Evangelista T, Abicht A, Dusl M, Lochmüller H. Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients. J Neurol 2018; 265:194-203.
  2. Barisic N, Müller JS, Paucic-Kirincic E, et al. Clinical variability of CMS-EA (congenital myasthenic syndrome with episodic apnea) due to identical CHAT mutations in two infants. Eur J Paediatr Neurol 2005; 9:7-12. 
  3. Kraner S, Laufenberg I, Strassburg HM, Sieb JP, Steinlein OK. Congenital myasthenic syndrome with episodic apnea in patients homozygous for a CHAT missense mutation. Arch Neurol 2003; 60:761-763.
  4. Ohno K, Tsujino A, Brengman JM, et al. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A 2001; 98:2017-2022.
  5. Liu ZM, Fang F, Ding CH, et al. Clinical and genetic characteristics of congenital myasthenia syndrome with episodic apnea caused by CHAT gene mutation: a report of 2 cases. Zhonghua Er Ke Za Zhi 2018; 56:216-220.

Related checklists

Loading...